Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on May 2, 2025

Snail Games 发布捷报,2025 年 4 月攻势如虹:王牌 IP 开疆拓土,独立恐怖 IP 新作面世,战略发行高歌猛进

Snail Games 发布捷报,2025 年 4 月攻势如虹:王牌 IP 开疆拓土,独立恐怖 IP 新作面世,战略发行高歌猛进

卡尔弗城,加利福尼亚州, May 02, 2025 (GLOBE NEWSWIRE) -- 作为全球领先的互动数字娱乐独立开发商和发行商,Snail, Inc. (Nasdaq: SNAL,以下简称“Snail Games”或“公司”) 今日公布了其 2025 年 4 月的卓越战绩,包括 ARK 系列的持续扩张,Bellwright 里程碑式的内容更新,以及该公司的独立游戏发行品牌 Wandering Wizard 旗下多款 IP 的发布。 ARK 系列内容焕新,魅力加倍 Snail Games …

Snail Games 報告稱 2025 年 4 月主要特許經營的擴展、新獨立恐怖 IP 發布及策略性發布增長帶來強大動力

Snail Games 報告稱 2025 年 4 月主要特許經營的擴展、新獨立恐怖 IP 發布及策略性發布增長帶來強大動力

卡爾弗城,加州, May 02, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商和發行商 Snail, Inc. (Nasdaq: Snal) (「Snail Games」或「公司」),今天重點介紹了其產品組合在 2025 年 4 月份的主要進程,包括 ARK 系列的擴展、Bellwright 的內容進程,以及公司獨立發行商品牌 Wandering Wizard 旗下的多個 IP 發布。 ARK 系列憑藉全新內容得以更上一層樓 Snail Games …

Equinor sells the Peregrino field for USD 3.5 billion

Equinor sells the Peregrino field for USD 3.5 billion

Equinor Brasil Energia Ltda., a subsidiary of Equinor (OSE: EQNR, NYSE: EQNR), has entered into agreements(1) with Brazilian company Prio Tigris Ltda., a subsidiary of PRIO SA (PRIO3.SA) for a sale of its 60% operated interest in the Peregrino field in …

Equinor selger Peregrino-feltet for 3,5 milliarder USD

Equinor selger Peregrino-feltet for 3,5 milliarder USD

Equinor Brasil Energia Ltda., et datterselskap av Equinor ASA (OSE:EQNR, NYSE: EQNR), har inngått avtaler(1) om salg av sin egenopererte eierandel på 60 prosent i Peregrino-feltet i Brasil med det brasilianske selskapet Prio Tigris Ltda. (PRIO3.SA). PRIO, …

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

Company Announcement Decision to submit based on a positive overall response rate (ORR) (p-value < 0.0001), one of the dual primary endpoints in the Phase 3 EPCORE® FL-1 trial Full results from the trial will be submitted for presentation at an upcoming …

ECG INVESTOR ALERT: Kirby McInerney LLP Notifies Everus Construction Group, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

ECG INVESTOR ALERT: Kirby McInerney LLP Notifies Everus Construction Group, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the June 3, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Everus …

UCTT INVESTOR ALERT: Kirby McInerney LLP Reminds Ultra Clean Holdings, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

UCTT INVESTOR ALERT: Kirby McInerney LLP Reminds Ultra Clean Holdings, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching May 23, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired …

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification

MANAUS, Brazil, May 01, 2025 (GLOBE NEWSWIRE) -- Brazil Potash Corp. ("Brazil Potash" or the "Company") (NYSE-American: GRO), a mineral exploration and development company with a critical mineral potash mining project, the Autazes Project, today announced …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service